BBP vs. SBIO
Compare and contrast key facts about Virtus LifeSci Biotech Products ETF (BBP) and ALPS Medical Breakthroughs ETF (SBIO).
BBP and SBIO are both exchange-traded funds (ETFs), meaning they are traded on stock exchanges and can be bought and sold throughout the day. BBP is a passively managed fund by Virtus Investment Partners that tracks the performance of the LifeSci Biotechnology Products Index. It was launched on Dec 17, 2014. SBIO is a passively managed fund by SS&C that tracks the performance of the S-Network Medical Breakthroughs Index. It was launched on Dec 31, 2014. Both BBP and SBIO are passive ETFs, meaning that they are not actively managed but aim to replicate the performance of the underlying index as closely as possible.
Performance
BBP vs. SBIO - Performance Comparison
Loading graphics...
BBP vs. SBIO - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
BBP Virtus LifeSci Biotech Products ETF | 4.77% | 33.15% | 3.32% | 17.88% | 0.85% | -8.17% | 22.24% | 24.73% | -13.95% | 24.07% |
SBIO ALPS Medical Breakthroughs ETF | 3.20% | 55.07% | 3.81% | 8.68% | -28.08% | -17.55% | 21.17% | 50.30% | -11.81% | 45.67% |
Returns By Period
In the year-to-date period, BBP achieves a 4.77% return, which is significantly higher than SBIO's 3.20% return. Over the past 10 years, BBP has outperformed SBIO with an annualized return of 12.85%, while SBIO has yielded a comparatively lower 9.75% annualized return.
BBP
- 1D
- 0.80%
- 1M
- -0.93%
- YTD
- 4.77%
- 6M
- 17.96%
- 1Y
- 47.40%
- 3Y*
- 19.33%
- 5Y*
- 9.54%
- 10Y*
- 12.85%
SBIO
- 1D
- 0.99%
- 1M
- 3.89%
- YTD
- 3.20%
- 6M
- 36.23%
- 1Y
- 95.78%
- 3Y*
- 26.37%
- 5Y*
- 1.76%
- 10Y*
- 9.75%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
BBP vs. SBIO - Expense Ratio Comparison
BBP has a 0.79% expense ratio, which is higher than SBIO's 0.50% expense ratio.
Return for Risk
BBP vs. SBIO — Risk / Return Rank
BBP
SBIO
BBP vs. SBIO - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Virtus LifeSci Biotech Products ETF (BBP) and ALPS Medical Breakthroughs ETF (SBIO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| BBP | SBIO | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 1.78 | 2.92 | -1.15 |
Sortino ratioReturn per unit of downside risk | 2.44 | 3.57 | -1.13 |
Omega ratioGain probability vs. loss probability | 1.30 | 1.45 | -0.15 |
Calmar ratioReturn relative to maximum drawdown | 3.20 | 5.66 | -2.46 |
Martin ratioReturn relative to average drawdown | 11.83 | 19.94 | -8.11 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| BBP | SBIO | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.78 | 2.92 | -1.15 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.37 | 0.05 | +0.31 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.47 | 0.29 | +0.18 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.40 | 0.23 | +0.17 |
Correlation
The correlation between BBP and SBIO is 0.89, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.
Dividends
BBP vs. SBIO - Dividend Comparison
Neither BBP nor SBIO has paid dividends to shareholders.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
BBP Virtus LifeSci Biotech Products ETF | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.18% | 0.00% | 1.29% |
SBIO ALPS Medical Breakthroughs ETF | 0.00% | 0.00% | 3.55% | 0.22% | 0.00% | 0.00% | 0.00% | 0.04% | 2.79% | 1.77% | 0.00% | 0.00% |
Drawdowns
BBP vs. SBIO - Drawdown Comparison
The maximum BBP drawdown since its inception was -44.32%, smaller than the maximum SBIO drawdown of -63.06%. Use the drawdown chart below to compare losses from any high point for BBP and SBIO.
Loading graphics...
Drawdown Indicators
| BBP | SBIO | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -44.32% | -63.06% | +18.74% |
Max Drawdown (1Y)Largest decline over 1 year | -13.38% | -15.08% | +1.70% |
Max Drawdown (5Y)Largest decline over 5 years | -38.28% | -53.67% | +15.39% |
Max Drawdown (10Y)Largest decline over 10 years | -44.32% | -63.06% | +18.74% |
Current DrawdownCurrent decline from peak | -3.12% | -13.79% | +10.67% |
Average DrawdownAverage peak-to-trough decline | -12.16% | -28.70% | +16.54% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 3.62% | 4.28% | -0.66% |
Volatility
BBP vs. SBIO - Volatility Comparison
The current volatility for Virtus LifeSci Biotech Products ETF (BBP) is 10.64%, while ALPS Medical Breakthroughs ETF (SBIO) has a volatility of 12.61%. This indicates that BBP experiences smaller price fluctuations and is considered to be less risky than SBIO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| BBP | SBIO | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 10.64% | 12.61% | -1.97% |
Volatility (6M)Calculated over the trailing 6-month period | 18.02% | 22.09% | -4.07% |
Volatility (1Y)Calculated over the trailing 1-year period | 27.02% | 33.43% | -6.41% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 26.22% | 33.55% | -7.33% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 27.51% | 33.34% | -5.83% |